Science On Demand
Managing Sensitivity in NAb Assays: When Wide Dynamic Range Makes Yes Mean No and No Mean Yes
Access It Now!
Complete the form to view the recording.Share this resource:
As part of the 2020 Land O’ Lakes Virtual Conference, BioAgilytix's David Rusnak, Director, Bioanalytical Operations, gave a presentation exploring how sensitivity in neutralizing antibody assays can be managed. We're making the popular session accessible for your viewing as well!
Access the recording to hear David discuss:
- The interplay between assay drug concentration, MRD, and sensitivity in a NAb assay.
- Situations where a statistical signal to baseline calculation may be more appropriate than a "linear range".
- A simple statisical approach for justifying an assay drug concentration that may appear lower than typically recommended by current guidance.